Y. Kawakami, H. Kitani, S. Yuasa, M. Abe, M. Moriwaki, M. Kagoshima, M. Terasawa and T. Tahara, “Structural Optimization of 4-(2-Chlorophenyl)-9-methyl-6H-thieno [3, 2-f]-[1,2,4]triazolo[4,3-a][1,4]diazepines as Antagonists for Platelet Activating Factor: Pharmacological Contribution of Substituents at the 2- and 6-Positions of a Condensed Ring System,” European Journal of Medicinal Chemistry, Vol. 31, No. 9, 1996, pp. 683-692. doi:0223-5234(96)85877-6

has been cited by the following article:

• TITLE: Synthesis and Biological Evaluation of Novel Homopiperazine Derivatives as Anticancer Agents

  AUTHORS: Simin Teimoori, Kuppusamy Panjamurthy, Kambappa Vinaya, Doddakunche S. Prasanna, Sathees C. Raghavan, Kanchugarakoppal S. Rangappa

  KEYWORDS: Cancer Therapy, Cytotoxicity, 1, 4-Diazepane, Isocyanates, Isothiocyanates

  JOURNAL NAME: Journal of Cancer Therapy, Vol.2 No.4, October 12, 2011

  ABSTRACT: In search of new anticancer agents, a series of novel 1-benzhydryl-4-(substituted phenylcarboxamide / carbothioamide)-1,4-diazepane derivatives were designed, synthesized and characterized using 1H NMR, LCMS and elemental analysis. These molecules were evaluated for their anti-cancer activity by trypan blue exclusion and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay on B-cell leukemic cell line, Reh. Carboxamide moiety containing derivatives showed good activity compared to the corresponding carbothioamide derivatives. In particular, 4-benzhydryl-N-(3-chlorophenyl)-1,4-diazepane-1-carboxamide showed good activity with IC50 value of 18 µM.